| US 7,608,730 B2 | ||
| Process for the preparation of an anti-tumor platinum (II)—complex | ||
| Golak Chandra Maikap, Ghaziabad (India); Bhagat Raj, Ghaziabad (India); Pradipta Kumar, Ghaziabad (India); Kannan Vivekanandan, Ghaziabad (India); and Chandrakant Belwal, Ghaziabad (India) | ||
| Assigned to Fresenius Kabi Oncology Limited, New Delhi (India) | ||
| Appl. No. 10/588,397 PCT Filed Feb. 05, 2004, PCT No. PCT/IN2004/000035 § 371(c)(1), (2), (4) Date Mar. 26, 2008, PCT Pub. No. WO2005/075489, PCT Pub. Date Aug. 18, 2005. |
||
| Prior Publication US 2008/0207935 A1, Aug. 28, 2008 | ||
| Int. Cl. C07F 15/00 (2006.01) | ||
| U.S. Cl. 556—137 | 19 Claims |
1. A process for the preparation of a platinum (II) complex compound of general formula (I)
![]() wherein the conformation of 1,2-diaminocyclohexane is cis, trans-(l) or trans-(d) isomer and R1 and R2 combinedly make dicarboxylic acid anion having formulae II, III and IV
![]() i) reacting a compound of formula M2PtX4 wherein X represents thiocyanate or a halogen atom selected from Cl, Br, and I with 1,2-diaminocyclohexane to give a compound
of formula (V);
![]() ii) reacting the compound of formula (V) of step i), with a source of silver ion selected from a silver compound containing
divalent anion in presence of an aliphatic carboxylic acid or an aliphatic or aromatic sulphonic acid to give compound of
formula (VI)
![]() wherein R is —O—CO—R′ or O—SO2—R′, wherein R′ is H, an alkyl or an aryl group; and
iii) reacting the compound of formula (VI) of step ii), with a dicarboxylic acid or its salts to give the object platinum
(II) complex compound of formula (I).
|